-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orca-Q in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orca-Q in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orca-Q in Acute Myelocytic Leukemia (AML,...
-
Product Insights
NewMevion Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Mevion Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company provides radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving treatment benefits of traditional proton therapy systems. Mevion provides MEVION S250mx for scalable proton therapy solution...
-
Product Insights
NewQuarterly Rum pricing trends in Australia
Empower your strategies with our Quarterly Rum pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Whiskey pricing trends in Ukraine
Empower your strategies with our Quarterly Whiskey pricing trends in Ukraine report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Carbonates pricing trends in Australia
Empower your strategies with our Quarterly Carbonates pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Whiskey pricing trends in China
Empower your strategies with our Quarterly Whiskey pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewNet Present Value Model: Beam Therapeutics Inc’s BEAM-101
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Thematic Analysis
RNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Sector Analysis
Automotive Lighting Market Trends, Sector Overview and Forecast to 2028
Automotive Lighting Market Report Overview The automotive lighting market size was 182.1 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. Government and business associations have established regulations and standards for automotive lighting systems. Lighting performance must meet the standards in terms of brightness, color, and beam patterns according to those laws. In 2023, Asia-Pacific accounted for a significant share of the market. Automotive Lighting Market Outlook, 2023-2028 (Million Units) Buy the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Hyaluronidase (Recombinant, Human) + Immune Globulin (Human)) in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Hyaluronidase (Recombinant, Human) + Immune Globulin (Human)) in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Hyaluronidase (Recombinant, Human) + Immune Globulin...